GFAP and amyloidosis: Interestingly, GFAP, which is usually increased in gliosis associated with amyloid, showed significantly decreased levels at 12 months in the dKI mice (Fig. 8A, F, G, Fig.S7 A), similar to what we observed in the hippocampi of Unc5cKI/KI mice starting at 12 months.